A reduced ratio of aspartate aminotransferase (AST) to alanine aminotransferase (ALT) might be a surrogate measure of NAFLD, and is considered to be another aspect of hyperinsulinemia and insulin resistance [6, 8]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.